Top

Reactions Weekly

Published in:

01-10-2011 | Case report

Phenoxymethylpenicillin potassium

Development of penicillin-resistant S. agalacticae infection: case report

Published in: Reactions Weekly | Issue 1/2011

Excerpt

An event is serious (FDA MedWatch definition) when the patient outcome is:

death
life-threatening
hospitalisation
disability
congenital anomaly
requires intervention to prevent permanent impairment or damage

…

Longtin J, Vermeiren C, Shahinas D, Tamber GS, McGeer A, Low DE, Katz K, Pillai DR.Novel mutations in a patient isolate of Streptococcus agalactiae with reduced penicillin susceptibility emerging after long-term oral suppressive therapy. Antimicrobial Agents and Chemotherapy 55: 2983-5, No. 6, Jun 2011 - Canada

Title: Phenoxymethylpenicillin potassium
Development of penicillin-resistant S. agalacticae infection: case report
Publication date: 01-10-2011
Publisher: Springer International Publishing
Published in: Reactions Weekly / Issue 1/2011
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.2165/00128415-201113750-00091

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Phenoxymethylpenicillin potassium

Development of penicillin-resistant S. agalacticae infection: case report

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2011

Propafenone overdose

Men with colorectal cancer uninformed about ED

More than a third (38%) of patients treated with clopidogrel [Plavix] are also receiving CYP2C19 inhibitors

Ziprasidone

Tenofovir disoproxil fumarate

Valproic acid